Cardiology
From the Journals
PCSK9 inhibition cuts events in very-high-risk groups
ODYSSEY OUTCOMES analyses peg prior CABG and polyvascular disease as targets for alirocumab.
From the Journals
Impact of climate change on mortality underlined by global study
One remarkable aspect of this study is its size, wrote John R. Balmes, MD, the author of an editorial on the paper.
Latest News
Dapagliflozin meets primary endpoint in the DAPA-HF trial
AstraZeneca announces preliminary results in first heart failure trial in an SGLT2 inhibitor.
From the Journals
Diabetes effect in heart failure varies by phenotype
In a pan-Asian cohort of heart failure patients with diabetes, there were differences in cardiac remodeling between patients with preserved left...
From the Journals
Cardiovascular cost of smoking may last up to 25 years
While quitting smoking significantly reduces the risk of cardiovascular disease within five years, the elevated risk can persist for up to 25...
From the Journals
New biomarker model outmatches conventional risk factors for predicting mortality
Although the majority of these biomarkers have been associated with mortality before, this is the first study that shows their independent effect...
Pearl of the Month
How thin should we go?
Dr. Douglas S. Paauw describes the best approach to anticoagulation in patients with atrial fibrillation who are on anticoagulation, then have a...
From the Journals
Midlife hypertension is associated with subsequent risk of dementia
Elevated blood pressure in midlife is associated with risk of subsequent dementia, but whether the risk is treatable is unclear.
From the Journals
Study: Cardiac biomarkers predicted CV events in CAP
The results suggest a change in usual practice is needed to reduce cardiovascular community-acquired pneumonia complications, according to a study...
From the Journals
Algorithm boosts MACE prediction in patients with chest pain
High-sensitivity cardiac troponin measurements combined with ECG and clinical assessment can help rule out MACE and unstable angina.
From the Journals
Ambulatory BP monitoring slightly better than in-office measures for predicting cardiovascular outcomes
It’s probably best to save these techniques for specific patients.